NCT04718636View on ClinicalTrials.gov

A Study to Evaluate Effects of CC-99677 on the Pharmacokinetics of an Oral Contraceptive in Healthy Female Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

September 30, 2020

Primary Completion Date

August 3, 2021

Study Completion Date

August 3, 2021

Conditions
Healthy Volunteers
Interventions
DRUG

Oral Contraceptive (Ortho Tri-Cyclen or its generic equivalent)

Daily

DRUG

CC-99677

Daily

Trial Locations (3)

33143

Qps-Mra, Llc, Miami

78744

PPD Phase 1 Clinic, Austin

08053

Hassman Research Institute, Marlton

Sponsors

Lead Sponsor

Celgene
All Listed Sponsors
lead

Celgene

INDUSTRY

NCT04718636 - A Study to Evaluate Effects of CC-99677 on the Pharmacokinetics of an Oral Contraceptive in Healthy Female Participants | Biotech Hunter | Biotech Hunter